On January 14, 2019 Physicians’ Education Resource (PER), a leading resource for continuing medical education (CME), reported that it will conduct two CME-accredited satellite symposia on bladder cancer and renal cell carcinoma at the 2019 American Society of Clinical Oncology (ASCO) (Free ASCO Whitepaper) Genitourinary (GU) Cancers Symposium on Feb. 14 and 15 at the San Francisco Marriott Marquis in California, Phil Talamo, president of PER (Press release, Physicians’ Education Resource, JAN 14, 2019, View Source [SID1234532639]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
"We are thrilled to host two different programs on the changing landscape of treating bladder cancer and renal cell carcinoma during this year’s ASCO (Free ASCO Whitepaper) GU," Talamo said. "Our educational programs will feature experienced experts presenting new clinical evidence to help attendees make decisions on selecting the best therapies to optimize patient outcomes in two very difficult to treat tumor settings."
The PER satellite symposiums are:
Shifting Paradigms in Bladder Cancer: How Immunotherapeutic Strategies Are Changing Courses of Care will be held on Thursday, Feb. 14, from 7 to 9 p.m. PST in the Salon 8 Yerba Buena Ballroom, Lower B2 Level. The symposia will be chaired by Daniel P. Petrylak, M.D., professor of medicine and urology at Yale School of Medicine and co-director of the Signal Transduction Research Program at Yale Cancer Center. During this interactive symposium, renowned experts will discuss the impact of evolving evidence on the use of immuno-oncology agents, including combination strategies, in the management of bladder cancers. To register, click here.
Medical Crossfire: Crossroads in Advanced RCC Decision-Making: With Many Options, How Will You Treat Your Patient Today? … And Tomorrow? will be held on Friday, Feb. 15, from 7 to 9 p.m. PST in the Salon 8 Yerba Buena Ballroom, Lower B2 Level. The symposia will be chaired by Toni K. Choueiri, M.D., director of the Lank Center for Genitourinary Oncology, director of the Kidney Cancer Center, a senior physician at Dana-Farber Cancer Institute, and the Jerome and Nancy Kohlberg chair and professor of medicine at Harvard Medical School. During this case-based, interactive, live symposium, distinguished faculty members will review the most recent data and best practices. A lively debate and discussion between faculty and attendees will address clinical challenges and questions faced in daily practice. To register, click here.
Each satellite symposium is accredited by the Accreditation Council for Continuing Medical Education for 2.0 AMA PRA Category 1 Credits for physicians.